Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript
Lyell Immunopharma Inc LYEL
$16.73
β² +2.20%
(+$0.36)
Open
$16.50
Prev Close
$16.37
Day Range
$16.01 β $17.21
52W Range
$7.65 β $45.00
Market Cap
$390.38M
Beta
-0.08
EPS (TTM)
$-12.98
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-17 |
| Shares Out. | 23,330,000 |
| Website | lyell.com/ β |
| Phone | 13025310855 |
Lyell Immunopharma Inc is a publicly traded company under the ticker symbol LYEL on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
11 analysts (2026-05-01)
